Developer docs
API playgroundTry for free, no card

Search company profiles

Juno Pharma Canada Inc.

Full company profile

uuid02ltayf

Namestring
Juno Pharma Canada Inc.
Legal namestring
Juno Pharma Canada Inc.
Websiteurl
junopharma.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Juno Pharma Canada Inc. is a privately held Canadian specialty pharmaceutical company headquartered in Montreal, Quebec, with a secondary office in Mississauga, Ontario. Formed on April 1, 2025, through the merger of Juno Pharmaceuticals Corp. and Omega Laboratories Limited, the company develops, manufactures, markets, and distributes injectable and non-injectable medications for the Canadian healthcare industry and selected international markets. Its product portfolio spans hospital injectables (Sugammadex, NOROMBY/NOROMBY HP, Glucose 50% IV, Aminophylline, Famotidine), ophthalmic retail products (Bimatoprost Ophthalmic Solution 0.01% w/v), antiseptic skin preparations (STANHEXIDINE 2%/4%, Baxedin® 2%/20%/Pre-Op), phlebology/sclerotherapy agents (Sclerodex, Tromboject), and allergy/immunotherapy treatments marketed through the Omega Allergies & Immunotherapy sub-brand.

The company's core technical platform is its Health Canada- and U.S. FDA-approved sterile injectable manufacturing facility in Montreal, supported by GMP approvals for the EU, U.K., and Australia through Mutual Recognition Agreements. Manufacturing capabilities include aseptic filling and terminal sterilization, batch sizes from 50 to 500L, fill volumes from 1mL to 100mL, and automated/semiautomated/manual visual inspection. Endorsements from the European Medicines Agency and Japan's PMDA extend its regulatory reach. In addition to proprietary product manufacturing, Juno Pharma Canada offers contract development and manufacturing (CDMO) services covering formulation, aseptic filling, terminal sterilization, contract packaging, and visual inspection, alongside international product registration and export services.

The business operates across three revenue streams: direct pharmaceutical product sales to hospitals, pharmacies, and healthcare providers; CDMO/contract manufacturing services for pharmaceutical partners; and international product registration and licensing for export markets. GTM is executed via enterprise field sales and direct business development outreach (bd@junopharma.com), supplemented by a Shopify-based e-commerce catalog and the dedicated omegaallergies.ca channel. The company also maintains medical information, pharmacovigilance, and customer service functions, reflecting the regulatory obligations inherent to its pharmaceutical manufacturer status.

Short descriptiontext

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that develops, manufactures, and distributes sterile injectable, ophthalmic, antiseptic, phlebology, and allergy/immunotherapy products for hospitals, pharmacies, and healthcare providers, and offers CDMO services to pharmaceutical partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMontreal, Canada
HQ citystring
Montreal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, sterile injectable manufacturing, CDMO services, hospital pharmaceuticals, pharmaceutical distribution
Industry3 codes
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of proprietary and generic injectable and non-injectable medications through direct sales and distribution channels to healthcare providers

junopharma.com
2CDMO/Contract Manufacturing Services
TypeProfessional Services
Description

Contract manufacturing for sterile injectable medications, contract packaging, and pharmaceutical development services for partners

junopharma.com
3International Product Registration and Export
TypeLicensing Royalties
Description

Export and international registration of commercial sterile injectable products to other markets

junopharma.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Omega Allergies & Immunotherapy
Description

Division of Juno Pharma Canada focused on allergy products and immunotherapy.

junopharma.com
Core offering1 text field

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that manufactures, markets, and distributes a portfolio of sterile injectable and other specialty pharmaceutical products — including hospital injectables, antiseptics, phlebology products, allergy medications, and ophthalmic solutions — to hospitals, pharmacies, and healthcare providers in Canada and through licensed international partners. In parallel, the company offers CDMO (Contract Development and Manufacturing Organization) services to third-party pharmaceutical partners, leveraging its sterile injectable manufacturing platform.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company formed by the merger of Juno Pharmaceuticals Corp. and Omega Laboratories Limited (April 1, 2025). The company focuses on development, production, marketing, and distribution of injectable and non-injectable medications. The product portfolio spans: (1) Retail/Consumer Products including Bimatoprost Ophthalmic Solution for eye conditions, Sugammadex Injection, and Omega Allergies & Immunotherapy treatments; (2) Hospital/Hospital Products including Glucose IV Infusion, Aminophylline Injection, Famotidine Injection, and NOROMBY for sterile injectable medications; (3) Antiseptic Products including STANHEXIDINE and Baxedin® brand antiseptic solutions with various chlorhexidine gluconate concentrations; (4) Phlebology Products including Sclerodex and Tromboject for sclerotherapy; and (5) Contract Development & Manufacturing (CDMO) services for sterile injectables. The company operates Health Canada and FDA-approved manufacturing facilities with GMP approvals for EU, Australia, and UK markets.

Product and service6 records
1Sterile Injectable Hospital Products
2Antiseptic Products
CategoryAntiseptic pharmaceuticals
Description

Antiseptic pharmaceutical products distributed by Juno Pharma Canada Inc. to hospitals, pharmacies, and healthcare institutions for infection control and topical use.

3Phlebology Products
CategoryPhlebology pharmaceuticals
Description

Phlebology pharmaceutical products marketed by Juno Pharma Canada Inc. for the phlebology specialty, distributed to healthcare providers and pharmacies.

4Allergy Products (Omega Allergies)
CategoryAllergy pharmaceuticals
Description

Allergy medications marketed under the Omega Allergies branding, distributed by Juno Pharma Canada Inc. to retail pharmacies and healthcare consumers for allergy relief.

5Ophthalmic Solutions
CategoryOphthalmic pharmaceuticals
Description

Ophthalmic pharmaceutical solutions, including Bimatoprost-based eye care products, marketed by Juno Pharma Canada Inc. for the ophthalmic specialty and distributed through pharmacies and healthcare channels.

6CDMO Services
CategoryContract pharmaceutical manufacturing services
Description

Contract Development and Manufacturing Organization (CDMO) services provided by Juno Pharma Canada Inc. to pharmaceutical partners, leveraging the company's sterile injectable manufacturing capabilities for formulation, fill-finish, and related contract manufacturing needs.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Patheon, now part of Thermo Fisher's CDMO business, is a leading contract development and manufacturing organization serving pharmaceutical and biotech clients. Comparable to Juno's CDMO services in sterile injectable fill-finish, formulation development, and contract packaging for global pharma partners.

TypeEmerging player
Description

Gland Pharma is an India-based sterile injectable manufacturer with FDA, EMA, and other major regulatory approvals, focused on generic injectables for global markets. Comparable to Juno in multi-jurisdictional sterile injectable manufacturing capabilities and CDMO services targeting complex generics.

TypeBroad incumbent
Description

Baxter is a global incumbent in sterile injectable pharmaceuticals, IV solutions, and hospital products with FDA-approved manufacturing. Comparable to Juno as a broad incumbent player with overlapping hospital sterile injectable portfolio but operating at materially larger scale with a much wider product breadth.

TypeDirect peer
Description

Apotex is Canada's largest generic pharmaceutical manufacturer, producing sterile injectable and non-injectable generics with domestic and international distribution. Directly comparable to Juno Pharma Canada given overlapping Canadian generic injectable manufacturing, regulatory scope, and hospital-channel focus.

TypeDirect peer
Description

Fresenius Kabi is one of the largest global suppliers of sterile injectable pharmaceuticals, IV solutions, and clinical nutrition products. Comparable to Juno in sterile injectable manufacturing, hospital channel distribution, and multi-jurisdictional regulatory footprint including Health Canada and FDA approvals.

TypeBroad incumbent
Description

Teva is one of the world's largest generic pharmaceutical companies with a substantial sterile injectable portfolio. Comparable to Juno as a broad incumbent in generic injectables but operating globally at significantly larger scale with broader therapeutic coverage and biosimilar offerings.

TypeEmerging player
Description

Ache is a Brazilian specialty pharmaceutical company with growing sterile injectable and hospital product portfolios expanding into international markets. Comparable to Juno as an emerging player in sterile injectable specialty pharma targeting hospital channels and seeking international registration of complex generics.

TypeDirect peer
Description

Hikma is a leading generic sterile injectable manufacturer with a large CDMO business and multi-jurisdictional regulatory approvals. Directly comparable to Juno's sterile injectable focus, CDMO service offering, and product development for generic injectables across regulated markets.

9Sandoz (Novartis)
TypeBroad incumbent
Description

Sandoz is the global leader in generic pharmaceuticals, including sterile injectable generics, with extensive multi-jurisdictional regulatory coverage. Comparable to Juno as a broad incumbent generic injectables player but at vastly greater scale with vertically integrated API and finished dose manufacturing.

TypeDirect peer
Description

Amphastar specializes in injectable and intranasal generic pharmaceuticals with in-house manufacturing capabilities and FDA-approved facilities. Comparable to Juno's focus on complex sterile injectable generics and proprietary sterile manufacturing capabilities targeting shortage-prone molecules.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Juno Pharma Canada Inc.

Specialty Pharmaceuticalsjunopharma.com

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that develops, manufactures, and distributes sterile injectable, ophthalmic, antiseptic, phlebology, and allergy/immunotherapy products for hospitals, pharmacies, and healthcare providers, and offers CDMO services to pharmaceutical partners.

What Juno Pharma Canada Inc. does

Juno Pharma Canada Inc. is a privately held Canadian specialty pharmaceutical company headquartered in Montreal, Quebec, with a secondary office in Mississauga, Ontario. Formed on April 1, 2025, through the merger of Juno Pharmaceuticals Corp. and Omega Laboratories Limited, the company develops, manufactures, markets, and distributes injectable and non-injectable medications for the Canadian healthcare industry and selected international markets. Its product portfolio spans hospital injectables (Sugammadex, NOROMBY/NOROMBY HP, Glucose 50% IV, Aminophylline, Famotidine), ophthalmic retail products (Bimatoprost Ophthalmic Solution 0.01% w/v), antiseptic skin preparations (STANHEXIDINE 2%/4%, Baxedin® 2%/20%/Pre-Op), phlebology/sclerotherapy agents (Sclerodex, Tromboject), and allergy/immunotherapy treatments marketed through the Omega Allergies & Immunotherapy sub-brand.

The company's core technical platform is its Health Canada- and U.S. FDA-approved sterile injectable manufacturing facility in Montreal, supported by GMP approvals for the EU, U.K., and Australia through Mutual Recognition Agreements. Manufacturing capabilities include aseptic filling and terminal sterilization, batch sizes from 50 to 500L, fill volumes from 1mL to 100mL, and automated/semiautomated/manual visual inspection. Endorsements from the European Medicines Agency and Japan's PMDA extend its regulatory reach. In addition to proprietary product manufacturing, Juno Pharma Canada offers contract development and manufacturing (CDMO) services covering formulation, aseptic filling, terminal sterilization, contract packaging, and visual inspection, alongside international product registration and export services.

The business operates across three revenue streams: direct pharmaceutical product sales to hospitals, pharmacies, and healthcare providers; CDMO/contract manufacturing services for pharmaceutical partners; and international product registration and licensing for export markets. GTM is executed via enterprise field sales and direct business development outreach (bd@junopharma.com), supplemented by a Shopify-based e-commerce catalog and the dedicated omegaallergies.ca channel. The company also maintains medical information, pharmacovigilance, and customer service functions, reflecting the regulatory obligations inherent to its pharmaceutical manufacturer status.

Juno Pharma Canada Inc. firmographics

Firmographics
Name
Juno Pharma Canada Inc.
Legal name
Juno Pharma Canada Inc.
Website
https://junopharma.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
101–250 employees
Short description
Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that develops, manufactures, and distributes sterile injectable, ophthalmic, antiseptic, phlebology, and allergy/immunotherapy products for hospitals, pharmacies, and healthcare providers, and offers CDMO services to pharmaceutical partners.
Ownership category
akta.pro rank

Juno Pharma Canada Inc. industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)

Keywords

  • Specialty pharmaceuticals
  • Sterile injectable manufacturing
  • CDMO services
  • Hospital pharmaceuticals
  • Pharmaceutical distribution

Where Juno Pharma Canada Inc. is headquartered

Location

Headquarters

HQ city
Montreal
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Juno Pharma Canada Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Pharmaceutical Product Sales: Sale of proprietary and generic injectable and non-injectable medications through direct sales and distribution channels to healthcare providers
  2. CDMO/Contract Manufacturing Services: Contract manufacturing for sterile injectable medications, contract packaging, and pharmaceutical development services for partners
  3. International Product Registration and Export: Export and international registration of commercial sterile injectable products to other markets

Go-to-market motion1 record

Distribution channels4 records

Marketing channels2 records

Juno Pharma Canada Inc. product offering

Product offering

Core offering

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that manufactures, markets, and distributes a portfolio of sterile injectable and other specialty pharmaceutical products — including hospital injectables, antiseptics, phlebology products, allergy medications, and ophthalmic solutions — to hospitals, pharmacies, and healthcare providers in Canada and through licensed international partners. In parallel, the company offers CDMO (Contract Development and Manufacturing Organization) services to third-party pharmaceutical partners, leveraging its sterile injectable manufacturing platform.

Product overview

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company formed by the merger of Juno Pharmaceuticals Corp. and Omega Laboratories Limited (April 1, 2025). The company focuses on development, production, marketing, and distribution of injectable and non-injectable medications. The product portfolio spans: (1) Retail/Consumer Products including Bimatoprost Ophthalmic Solution for eye conditions, Sugammadex Injection, and Omega Allergies & Immunotherapy treatments; (2) Hospital/Hospital Products including Glucose IV Infusion, Aminophylline Injection, Famotidine Injection, and NOROMBY for sterile injectable medications; (3) Antiseptic Products including STANHEXIDINE and Baxedin® brand antiseptic solutions with various chlorhexidine gluconate concentrations; (4) Phlebology Products including Sclerodex and Tromboject for sclerotherapy; and (5) Contract Development & Manufacturing (CDMO) services for sterile injectables. The company operates Health Canada and FDA-approved manufacturing facilities with GMP approvals for EU, Australia, and UK markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Omega Allergies & Immunotherapy: Division of Juno Pharma Canada focused on allergy products and immunotherapy.

Products and services

  • Sterile Injectable Hospital Products
  • Antiseptic Products Antiseptic pharmaceutical products distributed by Juno Pharma Canada Inc. to hospitals, pharmacies, and healthcare institutions for infection control and topical use.
  • Phlebology Products Phlebology pharmaceutical products marketed by Juno Pharma Canada Inc. for the phlebology specialty, distributed to healthcare providers and pharmacies.
  • Allergy Products (Omega Allergies) Allergy medications marketed under the Omega Allergies branding, distributed by Juno Pharma Canada Inc. to retail pharmacies and healthcare consumers for allergy relief.
  • Ophthalmic Solutions Ophthalmic pharmaceutical solutions, including Bimatoprost-based eye care products, marketed by Juno Pharma Canada Inc. for the ophthalmic specialty and distributed through pharmacies and healthcare channels.
  • CDMO Services Contract Development and Manufacturing Organization (CDMO) services provided by Juno Pharma Canada Inc. to pharmaceutical partners, leveraging the company's sterile injectable manufacturing capabilities for formulation, fill-finish, and related contract manufacturing needs.

Companies that use Juno Pharma Canada Inc.

Customer profile

Segments2 records

Ideal customer profiles3 records

Juno Pharma Canada Inc. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Juno Pharma Canada Inc. partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Juno Pharma Canada Inc. competitors and assessment

Company assessment

Direct peers

  • Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher's CDMO business, is a leading contract development and manufacturing organization serving pharmaceutical and biotech clients. Comparable to Juno's CDMO services in sterile injectable fill-finish, formulation development, and contract packaging for global pharma partners.
  • Apotex Inc. Apotex is Canada's largest generic pharmaceutical manufacturer, producing sterile injectable and non-injectable generics with domestic and international distribution. Directly comparable to Juno Pharma Canada given overlapping Canadian generic injectable manufacturing, regulatory scope, and hospital-channel focus.
  • Fresenius Kabi: Fresenius Kabi is one of the largest global suppliers of sterile injectable pharmaceuticals, IV solutions, and clinical nutrition products. Comparable to Juno in sterile injectable manufacturing, hospital channel distribution, and multi-jurisdictional regulatory footprint including Health Canada and FDA approvals.
  • Hikma Pharmaceuticals: Hikma is a leading generic sterile injectable manufacturer with a large CDMO business and multi-jurisdictional regulatory approvals. Directly comparable to Juno's sterile injectable focus, CDMO service offering, and product development for generic injectables across regulated markets.
  • Amphastar Pharmaceuticals: Amphastar specializes in injectable and intranasal generic pharmaceuticals with in-house manufacturing capabilities and FDA-approved facilities. Comparable to Juno's focus on complex sterile injectable generics and proprietary sterile manufacturing capabilities targeting shortage-prone molecules.

Emerging players

  • Gland Pharma: Gland Pharma is an India-based sterile injectable manufacturer with FDA, EMA, and other major regulatory approvals, focused on generic injectables for global markets. Comparable to Juno in multi-jurisdictional sterile injectable manufacturing capabilities and CDMO services targeting complex generics.
  • Ache Laboratorios Farmaceuticos: Ache is a Brazilian specialty pharmaceutical company with growing sterile injectable and hospital product portfolios expanding into international markets. Comparable to Juno as an emerging player in sterile injectable specialty pharma targeting hospital channels and seeking international registration of complex generics.

Broad incumbents

  • Baxter International: Baxter is a global incumbent in sterile injectable pharmaceuticals, IV solutions, and hospital products with FDA-approved manufacturing. Comparable to Juno as a broad incumbent player with overlapping hospital sterile injectable portfolio but operating at materially larger scale with a much wider product breadth.
  • Teva Pharmaceutical Industries: Teva is one of the world's largest generic pharmaceutical companies with a substantial sterile injectable portfolio. Comparable to Juno as a broad incumbent in generic injectables but operating globally at significantly larger scale with broader therapeutic coverage and biosimilar offerings.
  • Sandoz (Novartis): Sandoz is the global leader in generic pharmaceuticals, including sterile injectable generics, with extensive multi-jurisdictional regulatory coverage. Comparable to Juno as a broad incumbent generic injectables player but at vastly greater scale with vertically integrated API and finished dose manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Juno Pharma Canada Inc. compliance and trust

Trust signal

Compliance5 records

Juno Pharma Canada Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Juno Pharma Canada Inc. leadership team

Management profile

Number of profiles

Juno Pharma Canada Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Juno Pharma Canada Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Juno Pharma Canada Inc.

What does Juno Pharma Canada Inc. do?

Juno Pharma Canada Inc. is a Canadian specialty pharmaceutical company that manufactures, markets, and distributes a portfolio of sterile injectable and other specialty pharmaceutical products — including hospital injectables, antiseptics, phlebology products, allergy medications, and ophthalmic solutions — to hospitals, pharmacies, and healthcare providers in Canada and through licensed international partners. In parallel, the company offers CDMO (Contract Development and Manufacturing Organization) services to third-party pharmaceutical partners, leveraging its sterile injectable manufacturing platform.

Is Juno Pharma Canada Inc. a public or private company?

Juno Pharma Canada Inc. is a private company. It is classified as unknown and is currently operating.

When was Juno Pharma Canada Inc. founded?

Juno Pharma Canada Inc. was founded in 2025. It employs 101 to 250 people.

Where is Juno Pharma Canada Inc. based?

Juno Pharma Canada Inc. is headquartered in Montreal, Canada, in the North America region.

How does Juno Pharma Canada Inc. make money?

Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are CDMO/Contract Manufacturing Services and international Product Registration and Export.

Who are Juno Pharma Canada Inc.'s main competitors?

Direct peers on record are Patheon (Thermo Fisher Scientific), Apotex Inc., Fresenius Kabi, Hikma Pharmaceuticals and Amphastar Pharmaceuticals. Emerging players are Gland Pharma and Ache Laboratorios Farmaceuticos. Broad incumbents are Baxter International, Teva Pharmaceutical Industries and Sandoz (Novartis).

Does Juno Pharma Canada Inc. have an API?

No public API is recorded for Juno Pharma Canada Inc..

What industry is Juno Pharma Canada Inc. in?

Juno Pharma Canada Inc.'s product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales